13 - July - 2024
Lamst AlHayat Secures Exclusive Distribution Agreement with Global Biotherapeutics Leader CSL
Tripoli – Lamst AlHaya Company signed a strategic, exclusive distribution agreement with CSL, a world leader in Life-Saving Biotherapeutics. This partnership positions Lamst AlHaya as the sole supplier of CSL’s specialized product portfolio in Libya. The portfolio includes advanced biologic treatments for Hemophilia and immunodeficiency, high-efficacy influenza vaccines, and therapies for chronic iron deficiency and kidney diseases. The collaboration is crucial for ensuring sustainable access to global healthcare innovations, directly contributing to the improvement of clinical standards and overall patient care quality across the country.